Literature DB >> 11444830

Molecular cloning and characterization of a novel calcium/calmodulin-dependent protein kinase II inhibitor from human dendritic cells.

J Zhang1, N Li, J Yu, W Zhang, X Cao.   

Abstract

Calcium/calmodulin-dependent protein kinase II (CaMKII) is a widely distributed protein kinase that regulates numerous physiological functions. Inhibitors of CaMKII are useful tools for investigating the CaMKII functions. Here we identified a novel CaMKII inhibitor protein (CaM-KIIN) from the human dendritic cell cDNA library by large-scale random sequencing. Human CaM-KIIN contains 79 amino acids, which shares 98% identity and 98% positives with rat CaMKII inhibitor protein beta and 65% identity and 78% positives with rat CaMKII inhibitor alpha. Human CaM-KIIN mRNA expression was detectable in various tissues and cell lines by Northern blot and RT-PCR. To investigate its biological functions, full-length human CaM-KIIN was overexpressed in colon adenocarcinoma LoVo cells. When expressed in LoVo cells, it could inhibit cell proliferation, block cell growth, and decrease the viable cell number. These results characterize a potential cellular inhibitor protein of CaMKII that plays an important role in the regulation of cell growth. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444830     DOI: 10.1006/bbrc.2001.5175

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest and apoptosis through down-regulation of the phosphatidylinositide 3-kinase/Akt/HDM2 pathway.

Authors:  Shenglin Ma; Yunshan Yang; Chunmei Wang; Ning Hui; Linhui Gu; Haijun Zhong; Zhijian Cai; Qingqing Wang; Qinghua Zhang; Nan Li; Xuetao Cao
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

2.  A novel endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest via p27 stabilization.

Authors:  Chunmei Wang; Nan Li; Xingguang Liu; Yuanyuan Zheng; Xuetao Cao
Journal:  J Biol Chem       Date:  2008-02-27       Impact factor: 5.157

3.  Caloric restriction improves diabetes-induced cognitive deficits by attenuating neurogranin-associated calcium signaling in high-fat diet-fed mice.

Authors:  Hwajin Kim; Heeyoung Kang; Rok Won Heo; Byeong Tak Jeon; Chin-Ok Yi; Hyun Joo Shin; Jeonghyun Kim; Seon-Yong Jeong; Woori Kwak; Won-Ho Kim; Sang Soo Kang; Gu Seob Roh
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-05       Impact factor: 6.200

Review 4.  The emerging role of CaMKII in cancer.

Authors:  Yan-yang Wang; Ren Zhao; Hong Zhe
Journal:  Oncotarget       Date:  2015-05-20

Review 5.  CaMKII inhibitors: from research tools to therapeutic agents.

Authors:  Patricia Pellicena; Howard Schulman
Journal:  Front Pharmacol       Date:  2014-02-20       Impact factor: 5.810

6.  CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling.

Authors:  Tao Wang; Shuiming Guo; Zhuo Liu; Licheng Wu; Mingchao Li; Jun Yang; Ruibao Chen; Xiaming Liu; Hua Xu; Shaoxin Cai; Hui Chen; Weiyong Li; Shaohua Xu; Liang Wang; Zhiquan Hu; Qianyuan Zhuang; Liping Wang; Kongming Wu; Jihong Liu; Zhangqun Ye; Jun-Yuan Ji; Chenguang Wang; Ke Chen
Journal:  Oncotarget       Date:  2014-11-15

7.  MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression.

Authors:  Cheng Wu; Chunqing Miao; Qingsheng Tang; Xunrong Zhou; Pengshan Xi; Ping'an Chang; Lixin Hua; Haodong Ni
Journal:  J Cell Mol Med       Date:  2019-12-26       Impact factor: 5.310

8.  The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer.

Authors:  Tao Wang; Zhuo Liu; Shuiming Guo; Licheng Wu; Mingchao Li; Jun Yang; Ruibao Chen; Hua Xu; Shaoxin Cai; Hui Chen; Weiyong Li; Liang Wang; Zhiquan Hu; Qianyuan Zhuang; Shaohua Xu; Liping Wang; Jihong Liu; Zhangqun Ye; Jun-Yuan Ji; Chenguang Wang; Ke Chen
Journal:  Oncotarget       Date:  2014-06-15

9.  Functional Analyses of RUNX3 and CaMKIINα in Ovarian Cancer Cell Lines Reveal Tumor-Suppressive Functions for CaMKIINα and Dichotomous Roles for RUNX3 Transcript Variants.

Authors:  Karolin Heinze; Daniel Kritsch; Alexander S Mosig; Matthias Dürst; Norman Häfner; Ingo B Runnebaum
Journal:  Int J Mol Sci       Date:  2018-01-15       Impact factor: 5.923

Review 10.  Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer.

Authors:  Katie Joanna Miller; Mohammad Asim
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.